Replies to post #751121 on NorthWest Biotherapeutics Inc (NWBO)

[Jackxkr]

cost is objective lol , cost is never pure cost especially in manufacturing and construction, I know. lol

[FeMike]

There is a flaw in that argument. You are assuming 100% of the diluted shares are going to LP which we know are not.

There isn't a flaw in the argument, the hypothetical scenario that I posited simply uses easy, make believe numbers to show on an order of magnitude level how the benefit she gains from getting more shares outweighs the cost of dilution to her personally. I'm not assuming she gets 100% of the new shares, but the amount she gets easily overcomes the dilutive variable.

Also, that assumes that all shares received by Advent are all profit. Advent has overhead. From my recollection, Advent is being paid cost plus 15%.

No, it doesn't assume it's all profit. No part of what I said assumes or implies that. And no, Advent isn't being paid cost + 15. Advent is being paid FFF on milestones for development and production readiness, which is essentially the lion's share of the projects they have done to date. Advent's production contracts are, we assume based on contract language that we can see, cost+; but they have done very little work in this area so far. NWBO is paying Advent cash portions of milestone achievements that easily cover their overhead. NWBO is paying Advent stock comp on milestones as well, which for all intents and purposes are going straight to Linda as investment.

This theory doesn't make much sense.

Your counter doesn't make much sense, half of what you claim in it is demonstrably incorrect. Stop trying so hard to disprove me, and simply ponder to yourself for a second if what I say is true, does it make sense. And it makes perfect sense, I assure you.

[learningcurve2020]

Yeah, I’ve stressed this a number of times here but nobody seems interested. Subject is in the news now with NIH grants and Trump’s new directive.

>>paid cost plus

[manibiotech]

And the cost per treatment being ...... drum roll